{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:50:26Z","timestamp":1784289026312,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.urology.2023.05.016","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T04:46:20Z","timestamp":1685594780000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis\/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions"],"prefix":"10.1016","volume":"178","author":[{"given":"Galiya","family":"Raisin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dothan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolev","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natshe","family":"Ala-Adin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Kafka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Shenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Hatumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Malchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Moldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Chertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2023.05.016_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/iju.12085","article-title":"Intravesical drug delivery for dysfunctional bladder","volume":"20","author":"Hsu","year":"2013","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2023.05.016_bib2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s11255-022-03280-8","article-title":"Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study","volume":"54","author":"Dothan","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2023.05.016_bib3","article-title":"Intravesical drug delivery approaches for improved therapy of urinary bladder diseases","volume":"3","author":"Palugan","year":"2021","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.urology.2023.05.016_bib4","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.5489\/cuaj.4586","article-title":"CUA guideline on adult overactive bladder","volume":"11","author":"Corcos","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urology.2023.05.016_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1464-410x.2001.02227.x","article-title":"Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor","volume":"87","author":"Lose","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2023.05.016_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma","year":"2020","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2023.05.016_bib7","doi-asserted-by":"crossref","unstructured":"Marcu I, Campian EC, Tu FF. Interstitial cystitis\/bladder pain syndrome. Vol. 36, Seminars in Reproductive Medicine. Thieme Medical Publishers, Inc.; 2018:123-135.","DOI":"10.1055\/s-0038-1676089"},{"issue":"Suppl 1","key":"10.1016\/j.urology.2023.05.016_bib8","first-page":"S9","article-title":"Etiology, pathogenesis, and diagnosis of interstitial cystitis","volume":"4","author":"Sant","year":"2002","journal-title":"Rev Urol"},{"key":"10.1016\/j.urology.2023.05.016_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.urology.2015.01.021","article-title":"Beyond a simple anesthetic effect: lidocaine in the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"85","author":"Henry","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2023.05.016_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003804","article-title":"Continuous intravesical lidocaine treatment for interstitial cystitis\/bladder pain syndrome: safety and efficacy of a new drug delivery device","volume":"4","author":"Nickel","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.urology.2023.05.016_bib11","unstructured":"Te D., Jamison J. Intravesical treatments for painful bladder syndrome\/interstitial cystitis (Review) [Internet]. 2009. \u3008http:\/\/www.thecochranelibrary.com\u3009. Accessed May 1st, 2022."},{"key":"10.1016\/j.urology.2023.05.016_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/PL00007103","article-title":"Oxybutynin, and the overactive bladder","volume":"19","author":"Andersson","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2023.05.016_bib13","first-page":"306","article-title":"Effects of 1% lidocaine instillation on overactive bladder induced by bladder outlet obstruction in rats","volume":"17","author":"Kang","year":"2020","journal-title":"Urol J"},{"key":"10.1016\/j.urology.2023.05.016_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1590\/S1677-5538.IBJU.2015.0186","article-title":"Efficacy of tamsulosin, oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms","volume":"42","author":"Maldonado-Avila","year":"2016","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urology.2023.05.016_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/iju.13311","article-title":"Prevention, and treatment of symptoms associated with indwelling ureteral stents: a systematic review","volume":"24","author":"Betschart","year":"2017","journal-title":"Int J Urol"},{"issue":"8","key":"10.1016\/j.urology.2023.05.016_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1089\/end.2004.18.723","article-title":"Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy","volume":"18","author":"Beiko","year":"2004","journal-title":"J Endourol"},{"issue":"6","key":"10.1016\/j.urology.2023.05.016_bib17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/jgs.18279","article-title":"Longitudinal associations of anticholinergic medications on cognition and possible mitigating role of physical activity","volume":"71","author":"Norling","year":"2023","journal-title":"J Am Geriatr Soc"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429523004545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429523004545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:10:53Z","timestamp":1758769853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429523004545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":17,"alternative-id":["S0090429523004545"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2023.05.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742670264.793599077","asserted-by":"object"}]},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis\/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2023.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}